Aeliora

Aeliora is a specialized inhalation therapy containing helium and carbon monoxide, designed for respiratory support. This combination is often used to improve airflow and reduce inflammation in the lungs.

Aeliora is primarily used for respiratory conditions that require improved airflow and reduced inflammation. It may be prescribed for conditions like chronic obstructive pulmonary disease (COPD) or asthma, where traditional therapies may not be as effective. The helium component helps to reduce the effort required to breathe, while carbon monoxide can have anti-inflammatory effects.

When inhaled, Aeliora can help to reduce the resistance in the airways, making it easier to breathe. Users may experience a sense of relief from respiratory discomfort. The effects are typically felt soon after administration and can last for a significant period, depending on the individual's condition and response to the therapy.

Aeliora should be used under the guidance of a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully. Users should be aware of any potential allergic reactions to the components and discontinue use if adverse effects are experienced.

Aeliora may interact with other respiratory medications. It is important to inform your healthcare provider about all medications you are currently taking. Additionally, the use of Aeliora should be monitored closely if you are using other therapies that affect lung function.